A Practical Guide to Finding Clarity and Agency in Serious Illness CAIRO, NY, UNITED STATES — NEW BOOK REVEALS THE NEUROSCIENCE BEHIND CRISIS RESPONSE: “When Everything Changes” Offers Practical Framework …
Key Points Melbourne, Australia, July 6, 2026: Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to announce that it has engaged Pullan Consulting to provide business development services to assist …
Expert-led articles explain why dense breasts, mammograms, ultrasound, MRI, family history, and breast symptoms should be understood with medical context—not fear, confusion, or false reassurance. The Breast Cancer in Young …
We prioritize seeing referred patients quickly,” said Elizabeth Berry, MSN, ACNP-BC, Chief Nursing Officer of LiverRight. “The patient always remains the provider’s patient.” — Elizabeth Berry CINCINNATI, OH, UNITED STATES …
HOUSTON, TX — With more professionals spending long hours in front of computers, tablets, and smartphones, Texas State Optical At Briargrove is introducing a dedicated program focused on helping patients …
Leadership transition reflects Company’s growth, operational maturity, and commitment to scaling recovery-oriented care for people living with serious mental illness San Francisco, CA — Vanna Health, a value-based health technology …
Hanker Dating’s analysis of 120,000+ member relationships reveals diet as the single strongest predictor of relationship longevity in its dataset London — Hanker Dating, the elite invite-only matchmaking platform connecting …
GUNTUR, ANDHRA PRADESH, INDIA — Pediatric neurological disorders remain among the most challenging medical conditions affecting children worldwide, and according to Dr. Mohana Rao Patibandla, early diagnosis combined with advanced …
Focal brain injuries that produce psychiatric syndromes overnight are revealing the distributed networks whose disruption causes suffering. NEW YORK, NY, UNITED STATES — Consider, for a moment, the man who …
New York, NY – April 28, 2026 – Ambio Pharm Inc. announced today that its investigational peptide SCAM-47 (Synthetic Colloidally Aggregating Motif-47) has successfully completed Phase I clinical evaluation, with …
A News Publication Company.
